Abstract
Background Available outcomes data for anticoagulation therapy in adults with congenital heart disease ( CHD ) provide assessment of global risk of this therapy for CHD patients (a heterogeneous population), but the risk of complications for the different CHD diagnoses is unknown. The purpose of the study was to describe the indications for anticoagulation, and the incidence and risk factors for major bleeding complication in adults with tetralogy of Fallot. Methods and Results We queried Mayo Adult Congenital Heart Disease (MACHD) database for tetralogy of Fallot patients (aged ≥18 years) that received anticoagulation, 1990-2017. Of 130 patients (42±14 years, 75 men [58%]), warfarin and direct oral anticoagulants were used in 125 (96%) and 5 (4%), respectively because atrial arrhythmias (n=109), mechanical prosthetic valve (n=29), intracardiac thrombus (n=4), pulmonary embolism (n=6), stroke (n=3), and perioperative anticoagulation (n=44). The median hypertension, abnormal renal or liver function; stroke; bleeding history or predisposition; labile international normalized ratio; elderly (>65 years); drug or alcohol use score for the entire cohort was 1 (0-2) and 27 (21%) had hypertension, abnormal renal or liver function; stro...Continue Reading
References
Apr 22, 2005·Journal of Thrombosis and Haemostasis : JTH·S SchulmanUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Feb 28, 2009·Journal of the American College of Cardiology·Maurice Beghetti, Nazzareno Galiè
Mar 20, 2010·Chest·Ron PistersGregory Y H Lip
Mar 31, 2010·The Canadian Journal of Cardiology·Candice K SilversidesJudith Therrien
Aug 18, 2010·Circulation·Paul KhairyUNKNOWN Alliance for Adult Research in Congenital Cardiology (AARCC)
Aug 31, 2010·European Heart Journal·Helmut BaumgartnerUNKNOWN ESC Committee for Practice Guidelines (CPG)
Nov 30, 2010·Journal of the American College of Cardiology·Gregory Y H LipDeirdre A Lane
Feb 10, 2012·Circulation. Arrhythmia and Electrophysiology·Pilar GallegoGregory Y H Lip
Mar 1, 2012·Congenital Heart Disease·Julio SandovalCraig S Broberg
Mar 19, 2014·Clinical Biochemistry·Marcus LindJan-Håkan Jansson
Apr 2, 2014·Journal of the American College of Cardiology·Craig T JanuaryClyde W Yancy
Jul 6, 2014·Thrombosis Research·Ashkan LabafPeter J Svensson
Oct 5, 2014·Heart·A S JensenL Sondergaard
Dec 20, 2014·JACC. Cardiovascular Interventions·Jerrold H LevyJames Douketis
Jan 8, 2015·Heart·Jenna M FairclothGruschen R Veldtman
Apr 4, 2015·International Journal of Cardiology·J F HeidendaelB J Bouma
Jan 5, 2016·The American Journal of Cardiology·Claudia PujolHarald Kaemmerer
Aug 28, 2016·European Heart Journal·Paulus KirchhofUNKNOWN ESC Scientific Document Group
Aug 31, 2016·International Journal of Cardiology·Paul KhairyUNKNOWN Anticoagulation Therapy in Congenital Heart Disease (TACTIC) investigators and the Alliance for Adult Research in Congenital
Sep 17, 2016·Journal of the American College of Cardiology·Alexander C EgbeDavid J Driscoll
Dec 17, 2016·American Heart Journal·Alexander C EgbeDavid J Driscoll
Feb 18, 2017·International Journal of Cardiology·Keita MasudaKazutaka Aonuma
Oct 27, 2017·The Canadian Journal of Cardiology·Darryl WanSantabhanu Chakrabarti
Aug 20, 2018·Journal of the American College of Cardiology·Karen K StoutGeorge F Van Hare